期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
The role of B-type natriuretic peptide in the diagnosis and treatment of decompensated heart failure
1
作者 michaelj.gallagher PeterA.McCullough 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2004年第1期21-28,共8页
Heart failure (HF) is a common disease associated with increasing age. B-type natriuretic peptide (BNP), is a cardiac neurohormone, and is released as prepro BNP and then enzyrnatically cleaved to the Ntenninal-proBNP... Heart failure (HF) is a common disease associated with increasing age. B-type natriuretic peptide (BNP), is a cardiac neurohormone, and is released as prepro BNP and then enzyrnatically cleaved to the Ntenninal-proBNP (NT-proBNP) and BNP upon ventricular myocyte stretch. Blood measurements of BNP have been used to identify patients with I-IF. The BNP assay is currently used as a diagnostic and prognostic aid in HF. In general, a BNP level below 100 pg/mL excludes acutely decompensated HF and levels > 500 pg/ml indicate decompensation. Recombinant human BNP (hBNP, nesiritide) is an approved intravenous treatment for acute,decompensated -HF. Nesiritide given in supraphysiologic doses causes vasodilation, natriuresis, diuresis, and improved symptoms over the course of a 48-hour infusion. This paper will sort out the literature concerning the use of this peptide both as a diagnostic test and as an intravenous therapy. 展开更多
关键词 BNP The role of B-type natriuretic peptide in the diagnosis and treatment of decompensated heart failure TYPE
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部